Addex Therapeutics LTD. (ADXN) — SC 13D/A Filings

All SC 13D/A filings from Addex Therapeutics LTD.. Browse 2 SC 13D/A reports with AI-powered summaries and risk analysis.

SC 13D/A Filings (2)

Growth Equity Fund Adjusts Addex Therapeutics Stake — Aug 14, 2024 Risk: medium
On August 14, 2024, Growth Equity Opportunities Fund IV, LLC filed an amendment to its Schedule 13D, reporting a change in beneficial ownership of Addex Therape
Growth Equity Fund Updates Addex Therapeutics Stake — Aug 5, 2024 Risk: medium
On August 5, 2024, Growth Equity Opportunities Fund IV, LLC filed an amendment (No. 6) to its Schedule 13D regarding Addex Therapeutics Ltd. The filing indicate

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX